Atlassian’s Mike Cannon-Brookes invested in the startup via his investment company, Grok Ventures. Photo : Getty Images
Mike Cannon-Brookes, the billionaire cofounder of Australian software giant Atlassian, has invested $10 million in Juvenescence, a U.K. firm that’s trying to increase human longevity.
The average human life span currently sits at around 72 years, but billionaires are investing heavily in a handful of life science startups that hope to help people live longer.
Cannon-Brookes, who owns the most expensive house in Australia, participated in a $100 million series B funding round that was announced on Monday. The Sydney resident made the investment through his investment company, Grok Ventures.
Michael Spencer, former CEO of brokerage ICAP and one of the wealthiest men in Britain, also invested $10 million through his personal investment firm IPGL.
Read the full article at ‘Billionaire Mike Cannon-Brookes trying to increase human longevity‘